Health Care
![a woman and man sitting on a bench](https://uschamber.imgix.net/https%3A%2F%2Fwww.uschamber.com%2Fassets%2Fimages%2FGettyImages-1062188098-Healthcare-Cover.jpg?auto=compress%2Cformat&fit=clip&fm=jpg&q=10&w=100&s=bfd8cc32727524536360f553c538881a)
America has the most advanced health care in the world, in large part due to private sector-led innovation and employer-sponsored healthcare coverage.
While Americans benefit tremendously from ongoing advancements in bioscience, technology, and care, we continue to wrestle with the challenge of making quality health care more affordable, more accessible, and more reliable for all Americans. At the U.S. Chamber, we’re pushing for value-based healthcare solutions that reduce costs and reward quality outcomes.
Latest
Report
The United States is currently grappling with a nursing shortage that is causing a ripple effect of rising health care costs and lower quality of life across the country.
Spotlight on Mental Health
Become a part of the world’s largest business organization and network
U.S. Chamber members range from small businesses and chambers of commerce across the country to startups in fast-growing sectors, leading industry associations, and global corporations.
Discover the ROI Chamber membership can deliver for you.
Our Work
The U.S. Chamber is promoting effective private sector solutions to our health care challenges. These solutions will help control costs, expand access, and improve the quality of care. We support policy that strengthens the employer-based model of coverage, through which 180 million Americans receive—and overwhelmingly like—their health care.
Related Litigation
Events
- InfrastructureGlobal Aerospace Summit 2024Tuesday, September 10 - Wednesday, September 1108:00 AM EDT - 05:00 PM EDTLearn More
- Employment PolicyReimagining Futures: Second Chance Employment ForumWednesday, September 1802:00 PM EDT - 07:00 PM EDTLearn More
- Corporate Social ResponsibilityBusiness Solves: Strengthening Communities, Today and TomorrowTuesday, October 29 - Wednesday, October 3009:00 AM EDT - 05:00 PM EDTLearn More
Latest Content
Leading artists, innovators, and other IP champions light up the stage at this year’s event at the U.S. Chamber of Commerce.
The G20 Resource Efficiency Dialogue (hereinafter “the G20 RE Dialogue”) developed this Roadmap to promote its activities more effectively.
This Hill letter was sent to the U.S. House of Representatives, opposing H.R. 3, the “Lower Drug Costs Now Act of 2019.”
September 27 , 2019 Submitted Electronically Via Federal Rulemaking Portal: www.regulations.gov Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS -1717 -P P.O. Box 8013 Baltimore, MD 21244 -1850 Re: Medicare Hospital Outpatient Prospective Payment System for CY 2020 To Whom It May Concern:
As world leaders gather in New York for the United Nations General Assembly this week, here are the key global trends to watch.
We, the Ministers of Labour and Employment of G20 members and invited countries, met in Matsuyama, Japan on 1-2 September 2019 to discuss global developments with respect to employment, and progress on our previous commitments, and agree on policy prioritiesto address demographic change, new forms of work, and global efforts to realize gender equality.
Patrick Kilbride, Sr. Vice President, Global Innovation Policy Center, U.S. Chamber of Commerce made the following statement on the Health Canada Announcement of final amendments to the Patented Medicines Regulations:
On August 5, 2019 the U.S. Chamber of Commerce submitted comments to the Department of Health and Human Services in response to the agency's proposed rule that revises section 1557 non-discrimination rules to better comply with the Affordable Care Act's provision that prohibits "covered entities" from discriminating on the basis of sex, race, color, national origin, age, and disability in any health program or service.
WASHINGTON, D.C. — U.S. Chamber of Commerce Executive Vice President and Chief Policy Officer Neil Bradley released the following statement today in response to the U.S. Department of Health and Human Service’s proposed “Safe Importation Action Plan.”
This letter was sent to the Senate Committee on the Judiciary, on S. 64, the "Preserve Access to Affordable Generics and Biosimilars Act."